Antiepileptic Drug and Device Trials Conference; May 15-17 | Neurotech Investing and Partnering: May 23-24

AEDD XII May 15-17, 2013 Is this email not displaying correctly? View it in your browser. Donate Now » Follow Us On Twitter Friend Us On Facebook Forward To A Friend "Last year we saw some amazing and well-conceived ideas that opened our minds to entirely new products with near-term potential for patient trial and commercialization" --Jacqueline French, MD, Professor of Neurology, NYU School of Medicine; President, Epilepsy Study Consortium; President, American Epilepsy Society;  VP of Research, Epilepsy Therapy Project Register Today and attend the 12th Biennial Antiepileptic Drug Trials XII Conference, May 15-17, Turnberry Isle Resort, Aventura (North Miami Beach), Florida. On site registration is also available. This must attend event will bring together representatives from academia, industry, the NIH, and the FDA to review what has been learned and to discuss strategies to enhance AED development. Target Audience: Scientists engaged in drug, biologic, and device discovery for epilepsy or CNS, venture capitalists and other investors and business development and licensing professionals. Program Highlights Session I: Preclinical Drug Development and Early Clinical Development Session II: Preclinical Models: Beyond Efficacy Session III: Pediatrics Session IV: Assessment of Co-morbidities Session V: Targeting Treatment Resistance Session VI: Monotherapy Revisited Session VII: Trial Methodology Shark Tank Competition: Winner determined by live vote of "Sharks" and audience members. $100,000 awarded to the winner. Shark Tank Finalists: Mr. Giovanni Conte, Imparole, Milano, Italy Utkan Demirci, PhD, Brigham and Women's Hospital, Massachusetts Steven C. Schachter, MD, Harvard Medical School Bryan L. McLaughlin, PhD, Draper Laboratory Steven C. Schachter, MD, Harvard Medical School Georgia Mitsi, PhD, MBA, MSc, Apptomics LLC, Massachusetts Rosalind Picard, ScD, Massaschusetts Institute of Technology Jonathan Viventi, Polytechnic Institute of New York University Orrin Devinsky, MD, NYU Langone Medical Center, New York Meet our "Sharks": Stephen Collins, MD, PhD (Moderator), Gregory Grunberg, Joyce Cramer, Jim Jacoby, Roger J. Quy, PhD, Elizabeth S. Weiswasser   Networking Cocktail Reception Fostering new relationships and collaborations, join our networking reception and meet with with scientists, venture capitalists and other investors and business development and licensing professionals. 2013 Accelerator Award Celebration 2013 Recipient: Henrik Klitgaard, PhD Session VIII: Anti-Seizure Devices and Regulatory Issues Session IX: Regulatory Issues Session X: Drug Pipeline Session XI: Device Pipeline Full Program is available here. Registration Information Participant: $650.00  |  Clinical Coordinator/Nurse: $450.00 On Site Registration: $700.00 Register here:   AED Trials XII Website Investors, BD’s, Licensing Executives: Complimentary Registration Available For more information, please contact: Kim@epilepsytherapyproject.org Please join us for this important conference! Neurotech Investing and Partnering Conference May 23-24 in San Francisco! The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. This market defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics. Hear about next generation treatments for Alzheimer's, addiction, anxiety, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more. Conference Highlights: At The Neurotech Conference you'll get a first-hand glimpse of What's in the Pipeline Find out about new product licensing and partnering opportunities Learn what venture and strategic investors are looking for Discover emerging technologies and companies Learn about cutting edge translational research and funding opportunities Plan networking and schedule meetings ahead of time with other attendees Learn more and register today!

Copyright © 2013 Epilepsy Therapy Project, All rights reserved. You are receiving this email because you opted in at our website: www.epilepsy.com Our mailing address is: Epilepsy Therapy Project P.O. Box 742 Middleburg, VA 20118 Add us to your address book unsubscribe from this list | update subscription preferences